Abstract 2473 Leveraging the Privileged Pyridazine Chemotype Using Informatics and Structure Assisted Fragment Expansion for CNS Protein Kinase Inhibitor Design: A Bench to Clinic Case Study
S
Saktimayee Roy
L
Ludmilla Shuvalova
J
Joseph Brunzelle
G
George Minasov
O
Ottavio Arancio
D
Daniel Watterson
Article Details
Journal
Journal of Biological Chemistry
Volume / Issue
Vol. 301, Issue 5
Published
May 01, 2025
Pages
109070
ISSN
0021-9258
Publisher
Elsevier BV
Authors (6)
S
Saktimayee Roy
L
Ludmilla Shuvalova
J
Joseph Brunzelle
G
George Minasov
O
Ottavio Arancio
D
Daniel Watterson
Related Articles from this Journal
Asialoglycoprotein receptor subunit Asgr1a loss results in attenuated cholesterol absorption in zebrafish fed a western diet
Joshua T. Derrick, Tabea O.C. Moll et al.
Aug 2026
10.1016/j.jbc.2026.113239
Nrf2-mediated epigenetic priming of osmoprotective genes enhances cellular adaptation to hyperosmotic stress
Yi Lu, Na Li et al.
Aug 2026
10.1016/j.jbc.2026.113278
Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function
Kailash Venkatraman, Daniel Milshteyn et al.
Aug 2026
10.1016/j.jbc.2026.113306
Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression
Katerina-Marina Pilala, Artemis-Melina Papadimitriou et al.
Aug 2026
10.1016/j.jbc.2026.113302
Correction: Abstract 5588 Multifunctional carbon dots nanocarriers: Dual-drug delivery via π-π stacking interaction for stimuli-responsive chemotherapy and high oxidative stress
Girum Demissie, Jia Chang
Aug 2026
10.1016/j.jbc.2026.113253